Advertisement

Laser/Light Applications in Gynecology

  • Cornelia de Riese
  • Roger Yandell
Chapter

Abstract

The use of CO2 laser in the treatment of uterine cervical intraepithelial lesions is well established and indications, as well as techniques, have changed very little for over 30 years. The Cochrane Systematic Review from 2000 suggests no obviously superior technique. CO2 laser ablation of the vagina is also established as a safe treatment modality for VAIN (Vaginal Intraepithelial Neoplasia), and has been used extensively in the treatment of VIN (Vulvar Intraepithelial Neoplasia) and lower genital tract condylomata acuminata. CO2 laser permits treatment of lesions with excellent cosmetic and functional results. The treatment of heavy menstrual bleeding by destruction of the endometrial lining using various techniques, including Nd:YAG laser ablation, has been the subject of a 2002 Cochran Database Review. Among the compared treatment modalities are modified laser techniques. The conclusion by reviewers is that outcomes and complication profiles of newer techniques compare favorably with the gold standard of endometrial resection. Myoma coagulation or myolysis with Nd:YAG laser through the laparoscope or hysteroscope is a conservative treatment option for women who wish to preserve their child bearing potential.

Keywords

Human Papilloma Virus Cervical Intraepithelial Neoplasia Bacterial Vaginosis Human Papilloma Virus Infection Human Papilloma Virus Type 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Yandell RB et al. Evaluation of the KTP-532 nm laser for excisional cone biopsy of the cervix. Abstract presented at the Proceedings of the Combined Clinical Meeting of the American Society for Colposcopy and Cervical Pathology, and Gynecology Laser Society; April 1998.Google Scholar
  2. 2.
  3. 3.
    Schawlow AL. Sci Am. 1963;209:36.CrossRefGoogle Scholar
  4. 4.
    Schawlow AL, Townes CH. Physiol Rev. 1985;112:1940.Google Scholar
  5. 5.
    Patel CKN. High-power carbon dioxide lasers. Sci Am. 1968;219:23.CrossRefGoogle Scholar
  6. 6.
    Dorsey J. Application of laser in gynecology. In: TeLinde’s Operative Gynecology. 7th ed. Philadelphia: Lippincott; 1992:499.Google Scholar
  7. 7.
    Kaplan I et al. The treatment of erosions of the uterine cervix by means of the CO2 laser. Obstet Gynecol. 1973;41(5):795-796.PubMedGoogle Scholar
  8. 8.
    Bellina JH. Gynecology and the laser. Contrib Gynecol Obstet. 1974;5.Google Scholar
  9. 9.
    Bruhat MA. et al. Use of the CO2 laser via laparoscopy. In: Kaplan I, ed. Proceedings of the 3rd International Society for Laser Surgery. Tel Aviv: International Society for Laser Surgery; 1979:275.Google Scholar
  10. 10.
    Keye WR, Dixon J. Photocoagulation of endometriosis by the argon laser through the laparoscope. Obstet Gynecol. 1983;62:383.PubMedCrossRefGoogle Scholar
  11. 11.
    Goldrath M et al. Laser photo-vaporization of endometriosis for the treatment of menorrhagia. Am J Obstet Gynecol. 1981;140:14.PubMedGoogle Scholar
  12. 12.
    Rettenmaier MA et al. Photoradiation therapy of gynecologic malignancies. Gynecol Oncol. 1984;17:206.CrossRefGoogle Scholar
  13. 13.
    Insinga RP et al. The healthcare costs of cervical human papillomavirus-related disease. Am J Obstet Gynecol. 2004;191(1):114-120.PubMedCrossRefGoogle Scholar
  14. 14.
    Ho GY. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998;338:423.PubMedCrossRefGoogle Scholar
  15. 15.
    Munoz N et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518.PubMedCrossRefGoogle Scholar
  16. 16.
    Bosch FX et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J Natl Cancer Inst. 1995;87:796.PubMedCrossRefGoogle Scholar
  17. 17.
    Bonnez W, Reichman R. Papillomaviruses. In: Mandell, Douglas, Bennett, eds. Principles and Practice of Infectious Diseases. 6th ed. Philadelphia, PA: Churchill Livingstone; 2005:1841-1856.Google Scholar
  18. 18.
    Franco EL et al. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ. 2001;164:1017.PubMedGoogle Scholar
  19. 19.
    Burk RD et al. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis. 1996;23(4):333-341.PubMedCrossRefGoogle Scholar
  20. 20.
    Winer RL et al. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol. 2003;157:218.PubMedCrossRefGoogle Scholar
  21. 21.
    Tarkowski TA et al. Epidemiology of human papillomavirus infection and abnormal cytological test results in an urban adolescent population. J Infect Dis. 2004;189:46.PubMedCrossRefGoogle Scholar
  22. 22.
    Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med. 1997;102:3.PubMedCrossRefGoogle Scholar
  23. 23.
    Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol. 2005;32(suppl 1):S16-S24.PubMedCrossRefGoogle Scholar
  24. 24.
    Centers for Disease Control and Prevention Fact Sheet. Genital HPV Infection. www.edc.govlhvpl.
  25. 25.
    Dunne EF et al. Prevalence of HPV infection among females in the United States. JAMA. 2007;297:813.PubMedCrossRefGoogle Scholar
  26. 26.
    Dunne EF et al. Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis. 2006;194:1044.PubMedCrossRefGoogle Scholar
  27. 27.
    Castellsague X et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med. 2002;346(15):1105-1112.PubMedCrossRefGoogle Scholar
  28. 28.
    Clifford GM et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005;366:991.PubMedCrossRefGoogle Scholar
  29. 29.
    Carr J, Gyorfi T. Human papillomavirus. Epidemiology, transmission, and pathogenesis. Clin Lab Med. 2000;20:235.PubMedGoogle Scholar
  30. 30.
    Bonnez W, Reichman RC. Papillomaviruses. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 5th ed. Philadelphia: Churchill Livingston; 2000:1630.Google Scholar
  31. 31.
    Mackenzie-Wood A et al. Imiquimod 5% cream in the treatment of Bowen’s disease. J Am Acad Dermatol. 2001;44:462.PubMedCrossRefGoogle Scholar
  32. 32.
    Fazel N et al. Clinical, histopathologic, and molecular aspects of cutaneous human papillomavirus infections. Dermatol Clin. 1999;17:521.PubMedCrossRefGoogle Scholar
  33. 33.
    Llewellyn CD et al. Risk factors for squamous cell carcinoma of the oral cavity in young people – a comprehensive literature review. Oral Oncol. 2001;37:401.PubMedCrossRefGoogle Scholar
  34. 34.
    Uobe K et al. Detection of HPV in Japanese and Chinese oral carcinomas by in situ PCR. Oral Oncol. 2001;37:146.PubMedCrossRefGoogle Scholar
  35. 35.
    Sonnex C. Human papillomavirus infection with particular reference to genital disease. J Clin Pathol. 1998;51:643.PubMedCrossRefGoogle Scholar
  36. 36.
    Sedlacek TV. Advances in the diagnosis and treatment of human papillomavirus infections. Clin Obstet Gynecol. 1999;42:206.PubMedCrossRefGoogle Scholar
  37. 37.
    Baggish MS. Management of cervical intraepithelial neoplasia by carbon dioxide laser. Obstet Gynecol. 1982;60:378-384.PubMedGoogle Scholar
  38. 38.
    Martin-Hirsch PL et al. Surgery for cervical intraepithelial neoplasia. Cochrane Database Syst Rev. 2000;2:CD 001318.Google Scholar
  39. 39.
    Bar-Am A et al. Combined colposcopy, loop conization, and laser vaporization reduces recurrent abnormal cytology and residual disease in cervical dysplasia. Gynecol Oncol. 2000;78(1):47-51.PubMedCrossRefGoogle Scholar
  40. 40.
    Hullberg L et al. Menstrual blood loss: a population study. Acta Obstet Gynecol Scand. 1966;45:320-351.CrossRefGoogle Scholar
  41. 41.
    Martel P et al. Utilization of CO2 lasers in continuous or pulsed mode for conizations: apropos of 230 cases. Gynécol Obstét Fertil. 2000;28(7–8):537-546.PubMedGoogle Scholar
  42. 42.
    Moriyama M et al. CO2 laser conization for cervical intraepithelial neoplasia: a comparison with cold knife conization during pregnancy. Clin Laser Med Surg. 1991;9(2):115-120.Google Scholar
  43. 43.
    Van Rooijen M et al. Pregnancy outcome after laser vaporization of the cervix. Acta Obstet Gynecol Scand. 1999;78(4):346-348.PubMedCrossRefGoogle Scholar
  44. 44.
    Townsend DE et al. Treatment of vaginal carcinoma in situ with the carbon dioxide laser. Am J Obstet Gynecol. 1982;143:565-568.PubMedGoogle Scholar
  45. 45.
    Campagnutta E et al. Treatment of vaginal intraepithelial neoplasia (VAIN) with the carbon dioxide laser. Clin Exp Obstet Gynecol. 1999;26(2):127-130.PubMedGoogle Scholar
  46. 46.
    Curtin JP et al. Treatment of vaginal intraepithelial neoplasia with the CO2 laser. J Reprod Med. 1985;30:942-944.PubMedGoogle Scholar
  47. 47.
    Diakomanolis E et al. Vaginal intraepithelial neoplasia: report of 102 cases. Eur J Gynaecol Oncol. 2002;23(5):457-459.PubMedGoogle Scholar
  48. 48.
    Diakomanolis E et al. Treatment of vaginal intraepithelial neoplasia with laser ablation and upper vaginectomy. Gynecol Obstet Invest. 2002;54(1):17-20.PubMedCrossRefGoogle Scholar
  49. 49.
    Diakomanolis E et al. Conservative management of vaginal intraepithelial neoplasia (VAIN) by laser CO2. Eur J Gynaecol Oncol. 1996;17(5):389-392.PubMedGoogle Scholar
  50. 50.
    Hoffman MS et al. Laser vaporization of grade 3 vaginal intraepithelial neoplasia. Am J Obstet Gynecol. 1991;165:1342-1344.PubMedGoogle Scholar
  51. 51.
    Woodman CB et al. The management of vaginal intraepithelial neoplasia after hysterectomy. BJOG. 1984;91:707-711.CrossRefGoogle Scholar
  52. 52.
    Yalcin OT et al. Vaginal intraepithelial neoplasia: treatment by carbon dioxide laser and risk factors for failure. Eur J Obstet Gynecol Reprod Biol. 2003;106(1):64-68.PubMedCrossRefGoogle Scholar
  53. 53.
    Benedet JL. Epidermal thickness measurements in vaginal intraepithelial neoplasia. J Reprod Med. 1992;37:809-812.PubMedGoogle Scholar
  54. 54.
    Baggish MS, Dorsey JH. CO2 laser for the treatment of vulvar carcinoma in situ. Obstet Gynecol. 1981;57:371-375.PubMedGoogle Scholar
  55. 55.
    Baggish MS. Treating viral venereal infections with the CO2 laser. Reprod Med. 1982;27(12):737-774.Google Scholar
  56. 56.
    Hoffman MS et al. Laser vaporization for vulvar intraepithelial neoplasia III. J Reprod Med. 1992;37:135-137.PubMedGoogle Scholar
  57. 57.
    Sideri M et al. Evaluation of CO(2) laser excision or vaporization for the treatment of vulva intraepithelial neoplasia. Gynecol Oncol. 1999;75:277-281.PubMedCrossRefGoogle Scholar
  58. 58.
    Vessey MP et al. The epidemiology of hysterectomy: findings in a large cohort study. Br J Obstet Gynaecol. 1992;99:402-407.PubMedCrossRefGoogle Scholar
  59. 59.
    Lethaby A, Hickey M. Endometrial destruction techniques for heavy menstrual bleeding. Cochrane Database Syst Rev. 2002;2:CD 001501.Google Scholar
  60. 60.
    Jones K et al. Endometrial laser intrauterine thermotherapy for the treatment of dysfunctional uterine bleeding: the first British experience. Br J Obstet Gynaecol. 2001;108:749-753.CrossRefGoogle Scholar
  61. 61.
    Donnez J et al. Endometrial laser intrauterine thermotherapy: the first series of 100 patients observed for 1 year. Fertil Steril. 2000;74(4):791-796.PubMedCrossRefGoogle Scholar
  62. 62.
    Bhattacharya S et al. A pragmatic randomized comparison of transcervical resection of the endometrium with endometrial laser ablation for the treatment of menorrhagia. Br J Obstet Gynaecol. 1997;104:601-607.PubMedCrossRefGoogle Scholar
  63. 63.
    Phillips G et al. Risk of hysterectomy after 1000 consecutive endometrial laser ablations. Br J Obstet Gynaecol. 1998;105(8):897-903.PubMedCrossRefGoogle Scholar
  64. 64.
    Goldfarb HA. Myoma coagulation (myolysis). Obstet Gynecol Clin North Am. 2000;27(2):421-430.PubMedCrossRefGoogle Scholar
  65. 65.
    Nisolle M et al. Laparoscopic myolysis with the Nd:YAG laser. J Gynecol Surg. 1993;9:95.PubMedCrossRefGoogle Scholar
  66. 66.
    Chapman R. Low power interstitial photocoagulation of uterine leiomyomas by KTP/YAG laser. Lasers Med Sci. 1994;9:37-46.CrossRefGoogle Scholar
  67. 67.
    Chapman R. Low power interstitial photocoagulation of uterine leiomyomas by KTP/YAG laser: a review of 50 consecutive cases. SPIE Proc Med Appl Lasers II. 1994;2327:304-312.Google Scholar
  68. 68.
    Chapman R. Treatment of uterine leiomyomas by interstitial hyperthermia. Gynaecol Endosc. 1993;2:227-234.Google Scholar
  69. 69.
    Penna C et al. CO2 laser surgery for vulvar intraepithelial neoplasia. J Reprod Med. 2002;47:913-918.PubMedGoogle Scholar
  70. 70.
    Phillips DR et al. Experience with laparoscopic leiomyoma coagulation and concomitant operative hysteroscopy. J Am Assoc Gynecol Laparosc. 1997;4(4):425-433.PubMedCrossRefGoogle Scholar
  71. 71.
    Goldfarb HA. Laparoscopic coagulation of myoma (myolysis). Obstet Gynecol Clin North Am. 1995;22(4):807-819.PubMedGoogle Scholar
  72. 72.
    Chapman R. Treatment of large uterine fibroids. Br J Obstet Gynaecol. 1997;104:867-871.PubMedGoogle Scholar
  73. 73.
    Hindley JT et al. Clinical outcomes following percutaneous magnetic resonance image guided laser ablation of symptomatic uterine fibroids. Hum Reprod. 2002;17(10):2737-2741.PubMedCrossRefGoogle Scholar
  74. 74.
    Law P et al. Magnetic resonance-guided percutaneous laser ablation of uterine fibroids. J Magn Reson Imaging. 2000;12(4):565-570.PubMedCrossRefGoogle Scholar
  75. 75.
    Visvanathan D et al. Interstitial laser photocoagulation for uterine myomas. Am J Obstet Gynecol. 2002;187(2):382-384.PubMedCrossRefGoogle Scholar
  76. 76.
    Keckstein J. Laser techniques in gynaecology. Endosc Surg Allied Technol. 1994;2(3–4):176-180.PubMedGoogle Scholar
  77. 77.
    Donnez J. CO2 laser laparoscopy in infertile women with adhesions or endometriosis. Fertil Steril. 1987;48:390-394.PubMedGoogle Scholar
  78. 78.
    Nezhat C et al. Surgical treatment of endometriosis via laser laparoscopy. Fertil Steril. 1986;45:778-783.PubMedGoogle Scholar
  79. 79.
    Donnez J, Nisolle M. An Atlas of Operative Laparoscopy and Hysteroscopy. 2nd ed. New York/London: Parthenon Publishing; 2001.Google Scholar
  80. 80.
    Vercellini P et al. Coagulation or excision of ovarian endometriomas? Am J Obstet Gynecol. 2003;188(3):606-610.PubMedCrossRefGoogle Scholar
  81. 81.
    Jacobson TZ et al. Laparoscopic surgery for pelvic pain associated with endometriosis. Cochrane Database Syst Rev. 2001;4:CD 001300.Google Scholar
  82. 82.
    Divaris D et al. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin-IX fluorescence. Am J Pathol. 1990;136:891-897.PubMedGoogle Scholar
  83. 83.
    Kennedy JC et al. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B. 1990;1–2:143-148.CrossRefGoogle Scholar
  84. 84.
    Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B. 1992;4:275-292.CrossRefGoogle Scholar
  85. 85.
    Peng Q et al. 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol. 1997;65:235-251.PubMedCrossRefGoogle Scholar
  86. 86.
    Hillemanns P et al. Photodynamic therapy in women with cervical intra-epithelial neoplasia using topically applied 5-aminolevulinic acid. Int J Cancer. 1999;81:34-38.PubMedCrossRefGoogle Scholar
  87. 87.
    Tromberg BJ et al. In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy. Photochem Photobiol. 1990;2:375-385.CrossRefGoogle Scholar
  88. 88.
    Foote CS. Definition of type I and type II photosensitized oxidation. Photochem Photobiol. 1991;5:659.CrossRefGoogle Scholar
  89. 89.
    Ochsner M. Photophysical and photobiological processes in the photodynamic therapy of tumours. Photochem Photobiol. 1997;39:1-18.Google Scholar
  90. 90.
    Fan KFM et al. Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity. Cancer. 1996;78:1374-1383.PubMedCrossRefGoogle Scholar
  91. 91.
    Wolf P et al. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas? J Am Acad Dermatol. 1993;1:17-21.CrossRefGoogle Scholar
  92. 92.
    Scholefield JH. Treatment of grade III anal intraepithelial neoplasia with photodynamic therapy: report of a case. Dis Colon Rectum, 2003; 46(11):1555-1559. Tech Coloproctol. 2004;8:200.PubMedCrossRefGoogle Scholar
  93. 93.
    Webber J, Fromm D. Photodynamic therapy for carcinoma in situ of the anus. Arch Surg. 2004;139:259-261.PubMedCrossRefGoogle Scholar
  94. 94.
    Hamdan KA et al. Treatment of grade III anal intraepithelial neoplasia with photodynamic therapy: report of a case. Dis Colon Rectum. 2003;46:1555-1559.PubMedCrossRefGoogle Scholar
  95. 95.
    Hillemanns P et al. Photodynamic therapy of vulvar intraepithelial neoplasia using 5-aminolevulinic acid. Int J Cancer. 2000;85:649-653.PubMedCrossRefGoogle Scholar
  96. 96.
    Fehr MK et al. Photodynamic therapy of vulvar intraepithelial neoplasia III using topically applied 5-aminolevulinic acid. Gynecol Oncol. 2001;80:62-66.PubMedCrossRefGoogle Scholar
  97. 97.
    Morton CA et al. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen’s disease. Br J Dermatol. 1996;5:766-771.CrossRefGoogle Scholar
  98. 98.
    Martin-Hirsch PL. Photodynamic treatment for lower genital tract intraepithelial neoplasia [letter]. Lancet. 1998;351:1403.PubMedCrossRefGoogle Scholar
  99.  99.
    Lobraico RV, Grossweiner LI. Clinical experiences with photodynamic therapy for recurrent malignancies of the lower female genital tract. J Gynecol Surg. 1993;9:29-34.PubMedCrossRefGoogle Scholar
  100. 100.
    Fehr MK et al. Photodynamic Therapy of vulvar and vaginal condyloma and intraepithelial neoplasia using topically applied 5-aminolevulinic acid. Lasers Surg Med. 2002;30:273-279.PubMedCrossRefGoogle Scholar
  101. 101.
    Wierrani F et al. 5-Aminolevulinic acid-mediated photodynamic therapy of intraepithelial neoplasia and human papillomavirus of the uterine cervix–a new experimental approach. Cancer Detect Prev. 1999;23:351-355.PubMedCrossRefGoogle Scholar
  102. 102.
    Hillemanns P et al. Photodynamic therapy of vulvar lichen sclerosus with 5- aminolevulinic acid. Obstet Gynecol. 1999;93:71-74.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2011

Authors and Affiliations

  1. 1.Obstetrics and GynecologyTexas Tech University Health Sciences CenterLubbockUSA

Personalised recommendations